Healthcare -
Biotechnology - NASDAQ - US
$ 2.74
12.8 %
$ 134 M
Market Cap
-1.27
P/E
CABA - TOTAL EQUITY
Total Equity CABA - Cabaletta Bio, Inc.
236 M
LAST VALUE
41.51%
2 YEAR CAGR
88.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR